Short answer
Intellia Therapeutics, Inc. (NTLA) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected Muna Bhanji, Brian Goff and Jesse Goodman as Class I directors through 2029.
Intellia Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected Muna Bhanji, Brian Goff and Jesse Goodman as Class I directors through 2029
- Director support varied materially, with 43,004,221 to 57,065,465 votes for election
- Deloitte & Touche LLP ratified as independent auditor for fiscal 2026, with 87,833,534 votes in favor
- Executive compensation approved on an advisory basis, with 44,806,637 votes for and 13,821,404 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Intellia Therapeutics, Inc. 8-K filings
Get the next NTLA 8-K as it lands
Follow NTLA for push alerts, or ask the research agent what this filing means.